KERX - Keryx Biopharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts8877
Avg. Estimate-0.18-0.16-0.59-0.2
Low Estimate-0.25-0.22-0.81-0.32
High Estimate-0.14-0.13-0.47-0.03
Year Ago EPS-0.21-0.77-1.43-0.59
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts5577
Avg. Estimate21.98M25.24M106.87M171.55M
Low Estimate19M23M94.5M128.7M
High Estimate24.33M26.54M114.31M239.7M
Year Ago Sales11.82M15.14M60.46M106.87M
Sales Growth (year/est)86.00%66.70%76.80%60.50%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.-0.2-0.18-0.18-0.18
EPS Actual-0.21-0.77-0.2-0.26
Difference-0.01-0.59-0.02-0.08
Surprise %-5.00%-327.80%-11.10%-44.40%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.18-0.16-0.59-0.2
7 Days Ago-0.18-0.16-0.59-0.2
30 Days Ago-0.18-0.16-0.59-0.2
60 Days Ago-0.17-0.15-0.59-0.18
90 Days Ago-0.14-0.13-0.44-0.08
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesKERXIndustrySectorS&P 500
Current Qtr.14.30%N/AN/A0.42
Next Qtr.79.20%N/AN/A0.38
Current Year58.70%N/AN/A0.20
Next Year66.10%N/AN/A0.10
Next 5 Years (per annum)116.20%N/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A